Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.

Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in 9 sarcomeric protein genes. The most commonly affected is beta-myosin heavy chain (MYH7), where missense mutations cluster in the head and neck regions and directly affect motor function. Comparable mutations have not been describe...

Full description

Bibliographic Details
Main Authors: Blair, E, Redwood, C, de Jesus Oliveira, M, Moolman-Smook, J, Brink, P, Corfield, V, Ostman-Smith, I, Watkins, H
Format: Journal article
Language:English
Published: 2002
_version_ 1797072351675809792
author Blair, E
Redwood, C
de Jesus Oliveira, M
Moolman-Smook, J
Brink, P
Corfield, V
Ostman-Smith, I
Watkins, H
author_facet Blair, E
Redwood, C
de Jesus Oliveira, M
Moolman-Smook, J
Brink, P
Corfield, V
Ostman-Smith, I
Watkins, H
author_sort Blair, E
collection OXFORD
description Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in 9 sarcomeric protein genes. The most commonly affected is beta-myosin heavy chain (MYH7), where missense mutations cluster in the head and neck regions and directly affect motor function. Comparable mutations have not been described in the light meromyosin (LMM) region of the myosin rod, nor would these be expected to directly affect motor function. We studied 82 probands with HCM in whom no mutations had been found in MYH7 exons encoding the head and neck regions of myosin nor in the other frequently implicated disease genes. Primers were designed to amplify exons 24 to 40 of MYH7. These amplimers were subjected to temperature modulated heteroduplex analysis by denaturing high-performance liquid chromatography. An Ala1379Thr missense mutation in exon 30 segregated with disease in three families and was not present in 200 normal chromosomes. The mutation occurred on two haplotypes, indicating that it was not a polymorphism linked with another disease-causing mutation. The position of this residue within the LMM region of myosin suggests that it may be important for thick filament assembly or for accessory protein binding. A further missense mutation in exon 37, Ser1776Gly, segregated with disease in a single family and was absent from 400 population-matched control chromosomes. Because the Ser1776 residue occupies a core position in the myosin rod at which the substitution of glycine is extremely energetically unfavorable, it is likely to disrupt the coiled-coil structure. We conclude that mutation of the LMM can cause HCM and that such mutations may act through novel mechanisms of disease pathogenesis involving myosin filament assembly or interaction with thick filament binding proteins.
first_indexed 2024-03-06T23:06:33Z
format Journal article
id oxford-uuid:6404e8a0-914c-441b-9267-489d4aa8c31e
institution University of Oxford
language English
last_indexed 2024-03-06T23:06:33Z
publishDate 2002
record_format dspace
spelling oxford-uuid:6404e8a0-914c-441b-9267-489d4aa8c31e2022-03-26T18:16:27ZMutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6404e8a0-914c-441b-9267-489d4aa8c31eEnglishSymplectic Elements at Oxford2002Blair, ERedwood, Cde Jesus Oliveira, MMoolman-Smook, JBrink, PCorfield, VOstman-Smith, IWatkins, HFamilial hypertrophic cardiomyopathy (HCM) is caused by mutations in 9 sarcomeric protein genes. The most commonly affected is beta-myosin heavy chain (MYH7), where missense mutations cluster in the head and neck regions and directly affect motor function. Comparable mutations have not been described in the light meromyosin (LMM) region of the myosin rod, nor would these be expected to directly affect motor function. We studied 82 probands with HCM in whom no mutations had been found in MYH7 exons encoding the head and neck regions of myosin nor in the other frequently implicated disease genes. Primers were designed to amplify exons 24 to 40 of MYH7. These amplimers were subjected to temperature modulated heteroduplex analysis by denaturing high-performance liquid chromatography. An Ala1379Thr missense mutation in exon 30 segregated with disease in three families and was not present in 200 normal chromosomes. The mutation occurred on two haplotypes, indicating that it was not a polymorphism linked with another disease-causing mutation. The position of this residue within the LMM region of myosin suggests that it may be important for thick filament assembly or for accessory protein binding. A further missense mutation in exon 37, Ser1776Gly, segregated with disease in a single family and was absent from 400 population-matched control chromosomes. Because the Ser1776 residue occupies a core position in the myosin rod at which the substitution of glycine is extremely energetically unfavorable, it is likely to disrupt the coiled-coil structure. We conclude that mutation of the LMM can cause HCM and that such mutations may act through novel mechanisms of disease pathogenesis involving myosin filament assembly or interaction with thick filament binding proteins.
spellingShingle Blair, E
Redwood, C
de Jesus Oliveira, M
Moolman-Smook, J
Brink, P
Corfield, V
Ostman-Smith, I
Watkins, H
Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title_full Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title_fullStr Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title_full_unstemmed Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title_short Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
title_sort mutations of the light meromyosin domain of the beta myosin heavy chain rod in hypertrophic cardiomyopathy
work_keys_str_mv AT blaire mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT redwoodc mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT dejesusoliveiram mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT moolmansmookj mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT brinkp mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT corfieldv mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT ostmansmithi mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy
AT watkinsh mutationsofthelightmeromyosindomainofthebetamyosinheavychainrodinhypertrophiccardiomyopathy